Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

997217

registered interest
date	29/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Antimicrobials: Drug Resistance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 16 March 2018 to Question 132264 on Antibiotics: Drug Resistance, whether his Department has made an assessment of the potential merits of including (a) the latest electronic technology to reduce hospital infections and (b) other best practice on hand hygiene compliance in the prevention strand of the new antimicrobial resistance strategy.
tabling member constituency	Thirsk and Malton
tabling member printed	Kevin Hollinrake
uin	185000
answer	answer is ministerial correction date of answer 06/11/2018 answer text <p>Infection prevention and control will remain a key pillar of the United Kingdom’s upcoming five-year national action plan on antimicrobial resistance.</p><p> </p><p>NHS Improvement, who lead on infection prevention and control, has included a hand hygiene monitoring and compliance workstream in its current work programme.</p><p> </p><p>NHS Improvement has undertaken a rapid review of evidence on the use of electronic monitoring devices across the National Health Service to determine hand hygiene compliance. The technology used in some trusts is currently reliant on local data infrastructure and many existing systems would not be able to support it.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 06/11/2018 15:31:20 answering member 4067 label Biography information for Steve Brine
tabling member	4474 label Biography information for Kevin Hollinrake

714582

registered interest
date	28/03/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Antimicrobials: Drug Resistance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, when he expects the Global Antimicrobial Resistance Innovation Fund to be open to research applications for the repurposing of antibiotics.
tabling member constituency	Thirsk and Malton
tabling member printed	Kevin Hollinrake
uin	69526
answer	answer is ministerial correction date of answer 05/04/2017 answer text <p>The Government has committed £50 million towards setting up a Global Antimicrobial Resistance (AMR) Innovation Fund to increase global investment in AMR. The fund aims to leverage substantial new international investment in AMR research and development for new and repurposed antimicrobials and alternative medicines, rapid diagnostic tests, vaccines and other important technologies, interventions and therapies.</p><p>Professor Dame Sally Davies, the Chief Medical Officer for England and United Kingdom Government adviser, has appointed an expert advisory board to make recommendations on the scope and focus of the investment.</p><p>These discussions are ongoing.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood question first answered 05/04/2017 10:00:27 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	4474 label Biography information for Kevin Hollinrake

714584

registered interest
date	28/03/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Antimicrobials: Drug Resistance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, when he expects the first pilots of the Global Antimicrobial Resistance Innovation Fund on reimbursement models to incentivise the development of new classes of antibiotics to begin.
tabling member constituency	Thirsk and Malton
tabling member printed	Kevin Hollinrake
uin	69527
answer	answer is ministerial correction date of answer 05/04/2017 answer text <p>The Global Antimicrobial Resistance (AMR) Innovation Fund is a £50 million investment over five years to tackle AMR, with the aim of attracting significant additional investment internationally to stimulate global research. It is not looking at reimbursement models to incentivise the development of new classes of antibiotics or planning to fund pilots at this stage.</p><p>Domestically, the Department is working with the National Institute for Health and Care Excellence and the Association of the British Pharmaceutical Industry to develop a new reimbursement model for antimicrobials, and has secured broad agreement to principles that would permit a model to ‘de-link’ company revenues from sales. The aim of this work is to support good antimicrobial stewardship. Discussions with a number of leading pharmaceutical companies have highlighted challenges in evaluating antimicrobial medicines, and the Department is working closely with industry partners to address these.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood question first answered 05/04/2017 10:24:11 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	4474 label Biography information for Kevin Hollinrake